These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19879939)

  • 1. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease.
    Samoylenko V; Rahman MM; Tekwani BL; Tripathi LM; Wang YH; Khan SI; Khan IA; Miller LS; Joshi VC; Muhammad I
    J Ethnopharmacol; 2010 Feb; 127(2):357-67. PubMed ID: 19879939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease.
    Wang YH; Samoylenko V; Tekwani BL; Khan IA; Miller LS; Chaurasiya ND; Rahman MM; Tripathi LM; Khan SI; Joshi VC; Wigger FT; Muhammad I
    J Ethnopharmacol; 2010 Apr; 128(3):662-71. PubMed ID: 20219660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.
    Schwarz MJ; Houghton PJ; Rose S; Jenner P; Lees AD
    Pharmacol Biochem Behav; 2003 Jun; 75(3):627-33. PubMed ID: 12895680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Components of
    Santos BWL; Moreira DC; Borges TKDS; Caldas ED
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458698
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease.
    Fisher R; Lincoln L; Jackson MJ; Abbate V; Jenner P; Hider R; Lees A; Rose S
    Phytother Res; 2018 Apr; 32(4):678-687. PubMed ID: 29368409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
    McKenna DJ; Towers GH; Abbott F
    J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodiversity of β-Carboline Profile of
    Santos BWL; Oliveira RC; Sonsin-Oliveira J; Fagg CW; Barbosa JBF; Caldas ED
    Plants (Basel); 2020 Jul; 9(7):. PubMed ID: 32660098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).
    Herraiz T; González D; Ancín-Azpilicueta C; Arán VJ; Guillén H
    Food Chem Toxicol; 2010 Mar; 48(3):839-45. PubMed ID: 20036304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banisteriopsis caapi extract: Implications for neuroinflammatory pathways in Locus coeruleus lesion rodent model.
    Graça SC; Bustelli IB; Santos ÉVD; Fernandes CG; Lanaro R; Stilhano RS; Linardi A; Caetano AL
    J Ethnopharmacol; 2025 Jan; 337(Pt 1):118775. PubMed ID: 39244172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
    Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
    Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca.
    Berlowitz I; Egger K; Cumming P
    Front Pharmacol; 2022; 13():886408. PubMed ID: 35600851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by beta-carboline alkaloids occurring in foods and plants.
    Herraiz T; Chaparro C
    J Chromatogr A; 2006 Jul; 1120(1-2):237-43. PubMed ID: 16386263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.
    Morales-García JA; de la Fuente Revenga M; Alonso-Gil S; Rodríguez-Franco MI; Feilding A; Perez-Castillo A; Riba J
    Sci Rep; 2017 Jul; 7(1):5309. PubMed ID: 28706205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis.
    Callaway JC; Brito GS; Neves ES
    J Psychoactive Drugs; 2005 Jun; 37(2):145-50. PubMed ID: 16149327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various alkaloid profiles in decoctions of Banisteriopsis caapi.
    Callaway JC
    J Psychoactive Drugs; 2005 Jun; 37(2):151-5. PubMed ID: 16149328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessing the cultural and psychopharmacological significance of Banisteriopsis caapi: preparation, classification and use among the Piaroa of Southern Venezuela.
    Rodd R
    J Psychoactive Drugs; 2008 Sep; 40(3):301-7. PubMed ID: 19004422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic and Natural Monoamine Oxidase Inhibitors as Potential Lead Compounds for Effective Therapeutics.
    Pathak A; Srivastava AK; Singour PK; Gouda P
    Cent Nerv Syst Agents Med Chem; 2016; 16(2):81-97. PubMed ID: 26104056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.